Fredric D. Gordon, MD, FAASLD

Fredric D. Gordon, MD, FAASLD
Lahey Hospital and Medical Center
Burlington, MA

Fredric D. Gordon, MD is a board certified Gastroenterologist and Transplant Hepatologist, Vice Chair of the Division of Transplantation and Hepatobiliary Diseases, and Director of Hepatology at the Lahey Hospital & Medical Center in Burlington, Massachusetts. He is also an Associate Professor of Medicine at Tufts Medical School in Boston, Massachusetts.

Dr. Gordon received his undergraduate degree from Boston University and his medical degree from the Boston University School of Medicine. He completed his postgraduate training in Medicine at the New England Deaconess Hospital in Boston, where he later served as Chief Resident. He performed his Gastroenterology fellowship at Deaconess Hospital in Boston and his fellowship in Transplant Hepatology at the Mayo Clinic in Rochester, Minnesota.

Dr. Gordon has published over 150 articles, abstracts, and reviews regarding liver transplantation and tertiary treatment of hepatic disease. He serves on the editorial boards of the International Journal of Hepatology and as a reviewer for a number of prestigious journals including JAMA, the New England Journal of Medicine, and the American Journal of Gastroenterology. He has been the chair of the MELD Exceptions/Enhancements Subcommittee while on the OPTN/UNOS Liver & Intestine Committee, was a member of the AASLD Practice Guidelines. Committee, and is presently the chair of the Foundation Development Committee. His areas of research interest include liver transplantation, living donor adult liver transplantation, Hepatitis C, portal hypertension, and the Transjugular Intrahepatic Portosystemic Shunt (TIPS). In addition to his active clinical practice and academic appointments, Dr. Gordon is a frequently invited lecturer and presenter both nationally and internationally. He is a fellow of the American Association for the Study of Liver Disease, the American Society of Transplantation, and the American Gastroenterological Association, and a member of the International Liver Transplantation Society among others.

Disclosures of Potential Conflicts of Interest
Dr. Gordon has received research grants paid to his institution from Gilead, Intercept, Conatus, and Dova. He provides scientific consulting for Novartis. He serves on advisory and/or data safety monitoring boards for Galectin, Salubris, and PTC. He belongs to the speakers bureaus for AbbVie, CLDF, and Gilead. Dr. Gordon holds stock in Allurion Technologies and Salubris.